A detailed history of Stone X Group Inc. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Stone X Group Inc. holds 4,108 shares of GILD stock, worth $484,127. This represents 0.02% of its overall portfolio holdings.

Number of Shares
4,108
Previous 5,676 27.63%
Holding current value
$484,127
Previous $636 Million 28.38%
% of portfolio
0.02%
Previous 0.26%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 13, 2025

SELL
$96.91 - $113.0 $151,954 - $177,184
-1,568 Reduced 27.63%
4,108 $455 Million
Q1 2025

Aug 13, 2025

BUY
$89.14 - $117.41 $113,029 - $148,875
1,268 Added 28.77%
5,676 $636 Million
Q4 2024

Aug 13, 2025

SELL
$83.95 - $97.9 $179,149 - $208,918
-2,134 Reduced 32.62%
4,408 $407 Million
Q3 2024

Aug 13, 2025

BUY
$66.59 - $83.99 $37,490 - $47,286
563 Added 9.42%
6,542 $549 Million
Q2 2024

Aug 13, 2025

BUY
$63.15 - $72.88 $377,573 - $435,749
5,979 New
5,979 $410 Million
Q1 2024

Aug 13, 2025

SELL
$71.58 - $87.29 $347,449 - $423,705
-4,854 Reduced 42.1%
6,675 $489 Million
Q4 2023

Aug 13, 2025

BUY
$73.27 - $83.09 $844,729 - $957,944
11,529 New
11,529 $934 Million
Q4 2023

Feb 12, 2024

BUY
$73.27 - $83.09 $68,360 - $77,522
933 Added 8.81%
11,529 $934,000
Q3 2023

Aug 13, 2025

BUY
$73.94 - $80.67 $517,727 - $564,851
7,002 Added 70.49%
16,935 $1.27 Billion
Q3 2023

Nov 14, 2023

BUY
$73.94 - $80.67 $783,468 - $854,779
10,596 New
10,596 $794,000
Q2 2023

Aug 13, 2025

BUY
$76.01 - $86.7 $755,007 - $861,191
9,933 New
9,933 $766 Million
Q1 2023

Aug 13, 2025

BUY
$77.31 - $88.08 $242,366 - $276,130
3,135 Added 41.62%
10,668 $885 Million
Q1 2023

May 11, 2023

BUY
$77.31 - $88.08 $820,645 - $934,969
10,615 New
10,615 $881,000
Q4 2022

Aug 13, 2025

BUY
$62.32 - $89.47 $469,456 - $673,977
7,533 New
7,533 $647 Million
Q3 2022

Aug 13, 2025

BUY
$59.54 - $68.01 $170,582 - $194,848
2,865 Added 61.07%
7,556 $466 Million
Q3 2022

Nov 08, 2022

BUY
$59.54 - $68.01 $163,854 - $187,163
2,752 Added 58.67%
7,443 $459,000
Q2 2022

Aug 13, 2025

SELL
$57.72 - $65.01 $2,655 - $2,990
-46 Reduced 0.97%
4,691 $290 Million
Q2 2022

Jul 27, 2022

BUY
$57.72 - $65.01 $270,764 - $304,961
4,691 New
4,691 $290,000
Q1 2022

Aug 13, 2025

BUY
$57.92 - $72.58 $274,367 - $343,811
4,737 New
4,737 $282 Million
Q1 2022

May 11, 2022

SELL
$57.92 - $72.58 $269,270 - $337,424
-4,649 Closed
0 $0
Q4 2021

Aug 13, 2025

BUY
$64.88 - $73.64 $301,627 - $342,352
4,649 New
4,649 $337,000
Q4 2021

Feb 10, 2022

BUY
$64.88 - $73.64 $301,627 - $342,352
4,649 New
4,649 $338,000
Q3 2021

Oct 20, 2021

SELL
$67.69 - $73.03 $197,519 - $213,101
-2,918 Closed
0 $0
Q2 2021

Aug 06, 2021

BUY
$63.47 - $69.35 $185,205 - $202,363
2,918 New
2,918 $201,000
Q4 2018

Jan 15, 2019

SELL
$60.54 - $79.0 $229,204 - $299,094
-3,786 Closed
0 $0
Q3 2018

Oct 03, 2018

BUY
$71.28 - $78.92 $10,406 - $11,522
146 Added 4.01%
3,786 $0
Q2 2018

Jul 23, 2018

SELL
$64.88 - $75.68 $12,327 - $14,379
-190 Reduced 4.96%
3,640 $258,000
Q1 2018

Apr 19, 2018

BUY
$72.84 - $88.8 $7,502 - $9,146
103 Added 2.76%
3,830 $0
Q4 2017

Feb 09, 2018

BUY
$71.15 - $83.52 $51,583 - $60,552
725 Added 24.15%
3,727 $267,000
Q3 2017

Nov 13, 2017

SELL
$72.11 - $85.47 $914,066 - $1.08 Million
-12,676 Reduced 80.85%
3,002 $0
Q2 2017

Aug 31, 2017

BUY
N/A
15,678
15,678 $1.11 Million

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $148B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Stone X Group Inc. Portfolio

Follow Stone X Group Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Stone X Group Inc., based on Form 13F filings with the SEC.

News

Stay updated on Stone X Group Inc. with notifications on news.